Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3645 studies found for:    stem cell transplant | Interventional Studies
Show Display Options
Rank Status Study
1 Unknown  Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues Sarcomas
Conditions: Ewing;   Soft Tissue Sarcoma
Intervention: Procedure: Allogeneic hemopoietic stem cell transplant
2 Active, not recruiting Stem Cell Transplant for Immunologic or Histiocytic Disorders
Conditions: Hemophagocytic Lymphohistiocytosis;   X-Linked Lymphoproliferative Disorders;   Chediak-Higashi Syndrome;   Griscelli Syndrome;   Immunologic Deficiency Syndromes;   Langerhans-Cell Histiocytosis
Interventions: Procedure: Stem Cell Transplant;   Drug: Fludarabine, melphalan, ATG or Campath
3 Completed
Has Results
Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant
Conditions: Hodgkin's Disease;   Non Hodgkin's Lymphoma;   Myeloma;   Leukemia;   Myelodysplasia
Intervention: Drug: Non-myeloablative Stem Cell Transplantation
4 Recruiting Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Busulfan;   Drug: Palifermin;   Drug: Panobinostat;   Drug: Gemcitabine;   Drug: Melphalan;   Drug: Dexamethasone acetate;   Drug: Caphosol;   Drug: Glutamine;   Drug: Pyridoxine;   Procedure: Stem Cell Transplant
5 Completed Telemedicine Evaluation for Stem Cell Transplant Patients
Condition: Stem Cell Transplant Patients
Intervention: Behavioral: virtual medical visit
6 Terminated
Has Results
Stem Cell Transplant for Hematologic Diseases
Condition: Hematologic Malignancies
Interventions: Biological: Campath 1H;   Drug: Fludarabine;   Procedure: Stem Cell Transplant;   Radiation: Total Body Irradiation (TBI);   Drug: FK506 (Tacrolimus) or Cyclosporine
7 Completed
Has Results
Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)
Condition: Lymphoma, Non-Hodgkin
Intervention: Biological: Hematopoietic Stem Cell Transplant
8 Recruiting Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers
Conditions: Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Acute Myeloid Leukaemia;   Acute Lymphoblastic Leukaemia;   Myelodysplastic Syndrome;   Chronic Myeloid Leukaemia;   Chronic Lymphocytic Leukaemia;   Acquired Bone Marrow Failure Syndromes;   Other Haematological Malignancies; Unrelated HSCT Indicated
Interventions: Procedure: Reduced intensity haplodentical stem cell transplant;   Procedure: Myeloablative haploidentical stem cell transplant
9 Active, not recruiting High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma
Conditions: Non-Hodgkin's Lymphoma;   CNS Lymphoma
Intervention: Procedure: High-dose chemotherapy with autologous stem cell transplant
10 Completed Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome
Condition: Limbus Corneae Insufficiency Syndrome
Intervention: Procedure: Stem Cell with Amniotic Membrane Transplant
11 Terminated RO4929097 After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
Conditions: DS Stage I Plasma Cell Myeloma;   DS Stage II Plasma Cell Myeloma;   DS Stage III Plasma Cell Myeloma;   Refractory Plasma Cell Myeloma
Interventions: Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Drug: Gamma-Secretase Inhibitor RO4929097;   Procedure: Hematopoietic Stem Cell Mobilization;   Procedure: In Vitro-Treated Peripheral Blood Stem Cell Transplantation;   Other: Laboratory Biomarker Analysis;   Drug: Melphalan
12 Withdrawn The Clinical Trial Research of Stem Cell Transplantation Treats Cerebral
Condition: Stroke
Intervention: Procedure: stem cell transplantation
13 Completed Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients
Condition: Myelofibrosis
Intervention: Procedure: Allogeneic Stem Cell Transplantation
14 Unknown  Safety and Efficacy of Stem Cell Transplantation for Treatment of Liver Cirrhosis
Condition: Other Surgical Procedures
Intervention: Procedure: stem cell transplantation through interventional procedures
15 Not yet recruiting In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)
Conditions: Alpha Thalassemia Major;   Hemoglobinopathy; With Thalassemia;   Hemoglobinopathies;   Fetal Anemia;   Fetal Hydrops;   Alpha; Thalassemia;   Thalassemia Major;   Thalassemia Alpha;   A-Thalassemia
Intervention: Biological: in utero hematopoietic stem cell transplantation
16 Completed Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies
Conditions: Acute Lymphoblastic Leukemia (ALL);   Acute Myeloid Leukemia (AML);   Secondary AML;   Myelodysplastic Syndrome (MDS);   Secondary MDS;   Chronic Myeloid Leukemia;   Juvenile Myelomonocytic Leukemia (JMML);   Paroxysmal Nocturnal Hemoglobinuria (PNH);   Lymphoma, Non-Hodgkin;   Hodgkin Disease
Interventions: Procedure: Stem Cell Transplantation;   Device: Miltenyi Biotec CliniMACS;   Drug: Systemic chemotherapy and antibodies
17 Recruiting A Multicenter Phase I Study Evaluating the Addition of Bortezomib to an Established Acute Graft Versus Host Disease Prophylaxis Regimen in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients
Condition: Hematopoetic Stem Cell Transplant
Intervention: Drug: Bortezomib administration
18 Completed
Has Results
Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants
Conditions: Multiple Myeloma;   Plasma Cell Leukemia
Interventions: Drug: Bortezomib;   Drug: Melphalan;   Procedure: PBSCT
19 Active, not recruiting Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: GM-K562 vaccine;   Procedure: stem cell transplantation
20 Recruiting Stem Cell Transplantation for Stiff Person Syndrome (SPS)
Condition: Stiff Person Syndrome
Intervention: Biological: Autologous Hematopoietic Stem Cell Transplantation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.